Showing 13,081 - 13,100 results of 13,478 for search '"cancer treatment"', query time: 0.27s Refine Results
  1. 13081

    Novel Thiazolidine-2,4-dione-trimethoxybenzene-thiazole Hybrids as Human Topoisomerases Inhibitors by Maria Stefania Sinicropi, Jessica Ceramella, Patrice Vanelle, Domenico Iacopetta, Camillo Rosano, Omar Khoumeri, Shawkat Abdelmohsen, Wafaa Abdelhady, Hussein El-Kashef

    Published 2023-06-01
    “…Despite the encouraging advances made over the years in chemotherapy, the development of new compounds for cancer treatments is an urgent priority. In recent years, the design and chemical synthesis of several innovative hybrid molecules, which bring different pharmacophores on the same scaffold, have attracted the interest of many researchers. …”
    Get full text
    Article
  2. 13082
  3. 13083

    Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth by Mariafrancesca Scalise, Lorena Pochini, Michele Galluccio, Lara Console, Cesare Indiveri, Cesare Indiveri

    Published 2017-12-01
    “…Pharmacological compounds able to inhibit Glutamine metabolism may represent novel drugs for cancer treatments. Interestingly, well acknowledged targets for drugs are the Glutamine transporters of plasma membrane and the key enzyme Glutaminase.…”
    Get full text
    Article
  4. 13084

    Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment by Yasushi Shintani, Toru Kimura, Soichiro Funaki, Naoko Ose, Takashi Kanou, Eriko Fukui

    Published 2023-01-01
    “…Recent research has shown several roles of CAFs in NSCLC tumorigenesis, owing to their heterogeneity, so molecular markers of CAFs should be elucidated to better classify tumor-promoting subtypes and facilitate the establishment of CAF-specific targeted therapies. CAF-targeted cancer treatments may suppress EMT and regulate the niche of cancer stem cells and the immunosuppressive network and thus may prove useful for NSCLC treatment through multiple mechanisms.…”
    Get full text
    Article
  5. 13085

    MR imaging guided iron-based nanoenzyme for synergistic Ferroptosis−Starvation therapy in triple negative breast cancer by Duo Wang, Weimin Fang, Cuiqing Huang, Zerong Chen, Tianqi Nie, Jinghao Wang, Liangping Luo, Zeyu Xiao

    Published 2022-01-01
    “…Ferroptosis, a newly emerging antitumor strategy through enhancing iron-dependent lipid peroxides level to induce cancer cell death without the mediation of cell receptors, has been proved to be feasible in various cancer treatments. However, the high glutathione (GSH) level in tumor microenvironment limits the anti-tumor efficacy of ferroptosis. …”
    Get full text
    Article
  6. 13086

    Mistletoe Extracts during the Oncological Perioperative Period: A Systematic Review and Meta-Analysis of Human Randomized Controlled Trials by Elise Cogo, Mohamed Elsayed, Sukriti Bhardwaj, Kieran Cooley, Christilynn Aycho, Vivian Liang, Peter Papadogianis, Athanasios Psihogios, Dugald Seely

    Published 2023-09-01
    “…In five RCTs, ME was evaluated as adjunctive care and the control group had no additional intervention, whereas in two RCTs, ME was compared head-to-head against common cancer treatments (i.e., etoposide or bacillus Calmette-Guérin) with the intervention groups not receiving standard care. …”
    Get full text
    Article
  7. 13087

    Anti-cancer Effects of Methotrexate in Combination With Melissa officinalis on HeLa Cancer Cell Line by Parviz Faraji, Mostafa Araj-Khodaei, Amir Jafari, Maryam Ghaffari, Reza Mohammadinasab, Sanaz Hamedeyazdan, Miguel de la Guardia, Jafar Ezzati Nazhad Dolatabadi

    Published 2022-10-01
    “…Objectives: One of the well-accepted beliefs about natural products, considering the advances of recently appearing new edges and features of herbal medicine, is paying more attention to cancer treatments. However, they have not been properly studied with reasonable/reliable clinical trials in human subjects in most cases. …”
    Get full text
    Article
  8. 13088
  9. 13089

    Topical Drug Delivery of Concentrated Cabazitaxel in an α‐Tocopherol and DMSO Solution by Boyang Sun, Georgios Paraskevopoulos, Jiwei Min, Robert Rossdeutcher, Sanjana Ghosh, Breandan Quinn, Meng‐Hsuan Lin, Debanjan Sarkar, Dinesh Sukumaran, Yuefei Wang, Kateřina Vávrová, Jonathan F. Lovell, Yumiao Zhang

    Published 2023-10-01
    “…Abstract Topical chemotherapy approaches are relevant for certain skin cancer treatments. This study observes that cabazitaxel (CTX), a broad‐spectrum second‐generation taxane cytotoxic agent, can be dissolved in α‐tocopherol at high concentrations exceeding 100 mg mL−1. 2D nuclear magnetic resonance (NMR) analysis and molecular dynamics (MD) are used to study this phenomenon. …”
    Get full text
    Article
  10. 13090
  11. 13091
  12. 13092

    Analysis of the Reversible Impact of the Chemodrug Busulfan on Mouse Testes by Laura Thirouard, Hélène Holota, Mélusine Monrose, Manon Garcia, Angélique De Haze, Jean-Paul Saru, Françoise Caira, Claude Beaudoin, David H. Volle

    Published 2021-09-01
    “…It is well known that cancer treatments are associated with reversible or irreversible fertility disorders. …”
    Get full text
    Article
  13. 13093

    Targeting potential receptor molecules in non-small cell lung cancer (NSCLC) using in silico approaches by C. Kirubhanand, J. Merciline Leonora, S. Anitha, R. Sangeetha, K. T. Nachammai, K. Langeswaran, S. Gowtham Kumar

    Published 2023-02-01
    “…Chemotherapy, radiation therapy, and other conventional cancer treatments have a low success rate. Thus, creating new medications is essential to halt the spread of lung cancer.Methods: In this study bioactive nature of lochnericine against Non-Small Cell Lung Cancer (NSCLC) was analyzed using various computational approaches such as quantum chemical calculations, molecular docking, and molecular dynamic simulation. …”
    Get full text
    Article
  14. 13094

    In silico and in vitro studies on the anti-cancer activity of artemetin, vitexicarpin and penduletin compounds from Vitex negundo by Giau Van Vo, Thi-Hoai-Thu Nguyen, Thi-Phuong Nguyen, Thi-Hong-Tuoi Do, Nguyen-Minh-An Tran, Huy Truong Nguyen, Thuy Trang Nguyen

    Published 2022-09-01
    “…In addition, those compounds increased the level of reactive oxygen species production, induced cell death occurred via apoptosis, demonstrated by Annexin V-staining cells, contributed significantly to DNA damage, and led to the activation of caspase3/caspase8 pathways.Additionally, molecular docking was also conducted to rationalize the cancer cells inhibitory and to evaluate the ability of the FLV1, FLV2, and FLV3 compounds to be developed as good drug candidates for cancers treatment.…”
    Get full text
    Article
  15. 13095

    A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors by Charlotte Kerstens, Hans P. M. W. Wildiers, Gwen Schroyen, Mercedes Almela, Ruth E. Mark, Maarten Lambrecht, Sabine Deprez, Charlotte Sleurs

    Published 2023-02-01
    “…Individual risk factors included cancer subtypes (e.g., brain cancer, hormone-related cancers), treatment (e.g., anti-hormonal therapy, chemotherapy, cranial radiation), genetic predisposition (e.g., APOE, COMT, BDNF), age, comorbidities (e.g., frailty, cognitive reserve), and psychological (e.g., depression, (post-traumatic) distress, sleep, fatigue) and social factors (e.g., loneliness, limited caregiver support, low SES). …”
    Get full text
    Article
  16. 13096

    Aptamer Therapeutics in Cancer: Current and Future by Yoshihiro Morita, Macall Leslie, Hiroyasu Kameyama, David E. Volk, Takemi Tanaka

    Published 2018-03-01
    “…This review discusses the advantages and challenges of aptamers and introduces therapeutic aptamers under investigation and in clinical trials for cancer treatments.…”
    Get full text
    Article
  17. 13097

    Endothelial <i>Nogo-B</i> Suppresses Cancer Cell Proliferation via a Paracrine TGF-β/Smad Signaling by Hengyu Li, Zhuo Cheng, Pinghua Yang, Wei Huang, Xizhou Li, Daimin Xiang, Xiaojun Wu

    Published 2022-09-01
    “…These findings not only broaden our understanding of the crosstalk between cancer cells and endothelial cells but also provide a novel prognostic biomarker and a therapeutic target for cancer treatments.…”
    Get full text
    Article
  18. 13098

    Nephroprotective effects of Datura stramonium leaves against methotrexate nephrotoxicity via attenuation of oxidative stress-mediated inflammation and apoptosis in rats by Esther Alum, Ademola Famurewa, Obasi Orji, Patrick M Aja, Felix Nwite, Simon Ohuche, Stanley Ukasoanya, Lucy Nnaji, Deborah Joshua, Kingsley Igwe, Stephen Chima

    Published 2023-07-01
    “…Objective: Methotrexate (MTX) is a frontline antimetabolite anticancer drug which is used in different cancer treatments but its nephrotoxicity is a notable drawback that limits its clinical use. …”
    Get full text
    Article
  19. 13099

    THE INTEGRATIVE APPROACH TO THE PSYCHO- PHYSICAL REHABILITATION ISSUES OF BREAST CANCER SURVIVORS by Cristina Accetta, Daniela Belella, Annalisa Di Micco, Alessio Filippone, Cristina Rossi, Maria Maddalena Rossi, Claudia Maggiore, Luana Forcina, Maria Natale, Francesca Veccia, Daniela Pia Rosaria Chieffo, Riccardo Masetti, Stefano Magno

    Published 2024-01-01
    “…During and beyond cancer treatments, patients tend to reduce their physical activity levels, gain weight and may complain about chronic pain, lymphedema, fatigue, cognitive problems, depression and anxiety, reduced social contacts and difficulties in resuming daily activities. …”
    Get full text
    Article
  20. 13100

    Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance by Olga E. Andreeva, Danila V. Sorokin, Ekaterina I. Mikhaevich, Irina V. Bure, Yuri Y. Shchegolev, Marina V. Nemtsova, Margarita V. Gudkova, Alexander M. Scherbakov, Mikhail A. Krasil’nikov

    Published 2021-11-01
    “…Hormone therapy is one of the most effective breast cancer treatments, however, its application is limited by the progression of hormonal resistance, both primary or acquired. …”
    Get full text
    Article